Germany Breast Cancer Therapeutics Market Analysis


  • Type: Oncology area
  • Published : April 2021
  • Region: Europe
  • Country: Germany
  • Report ID : 2025

  • Format: PPT, PDF

Germany Breast Cancer Therapeutics Market: Segmented by therapy, cancer type, distribution channel, and drug type – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 2025 Categories: ,

Report Overview

Germany’s Breast Cancer Therapeutics market size stood at around USD XX.X billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 8.9% during the forecast period.

Increased Incidence coupled with growing awareness contributes to the growth of this market. The growing cases of breast cancer in the country further propel the demand for diagnostics and further treatment facilities for breast cancer thus contributing to the market growth. According to the quality assured Mammography Screening Program in Germany, women between 50 and 69 years of age are invited to an X-ray examination of the breasts every two years.

Market Driving and Restraining Factors

Market Drivers

The driving factors for the growth of the Breast Cancer Therapeutics market in Germany include:

    • Rising prevalence of Breast cancer
    • Growing healthcare spending for cancer
    • Launch of technologically advanced therapeutics

One of the foremost drivers influencing the growth of the German market is the increased prevalence of breast cancer across the world, which is expected to result in a large patient population demanding accurate and efficient treatment options. Furthermore, the increasing demand for preventive care and early treatment has led many individuals to undergo cancer screening tests, which would also strongly drive the number of patients demanding treatment in the forecast period. As the number of patients suffering from breast cancer continues to increase, the importance and the critical need for the development of advanced therapeutics for better outcomes remains unparalleled.

Restraining Factors

    • Adverse effects of therapeutics

Adverse reactions arising from breast cancer therapeutics, such as targeted therapies, may limit the market growth soon. In cases of severe adverse reactions, the patient may not be able to use that drug and may have to move toward other types of therapeutics.

Breast Cancer Stages

The stages of breast cancer are determined by cancer’s characteristics, such as how large it is and whether it has hormone receptors. These stages are classified as:

    • Stage 0
    • Stage I
    • Stage 2
    • Stage 3
    • Stage 4

Incidence rates in the observation period increased, as they were affected by the increasing number of cases with early-stage cancers being diagnosed in the screening age group. The total incidence of early-stage cancer, which included the incidence of non-invasive breast cancers, increased by 14.5% between 2005 and 2016.

Advanced stage breast cancer rates (UICC II+) started to decline during fully implemented screening program. Advanced stage breast cancer declines were not observed in women newly eligible for screening

Early-stage cancers (UICC stages 0 and I) increased by 48.1% while late-stage diagnoses (UICC stages III and IV) decreased by 31.6%.

These changes can be attributed to developing infrastructure and expertise in the breast cancer market.

1. Germany Breast Cancer Therapeutics Market Overview……………………….
A. Market Size
2. Market Driving and Restraining Factors…………………………….………….
A. Market Drivers
A. Rising prevalence of Breast cancer
B. Growing healthcare spending for cancer
C. Launch of technologically advanced therapeutics
B. Restraining Factors
A. Adverse effects of therapeutics
3. Breast Cancer Stages
A. Stage 0
B. Stage 1
C. Stage 2
D. Stage 3
E. Stage 4
4. Breast Cancer Therapeutics Market Segmentation…………………………
A. By Therapy
a. Chemotherapy
b. Hormone therapy
c. Targeted therapy
d. Radiation therapy
B. By Cancer Type
a. hormone receptor
b. HER2+
C. By Distribution Channel
a. Hospital pharmacies
b. Ambulatory Surgical Centres
c. Retail and Online pharmacies
D. By Drug Type
a. HER2 and Mitotic Inhibitors
b. Anti-metabolites
c. Aromatase Inhibitors
d. Hormonal Receptors
5. Breast Cancer Major Products Market Share………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. AstraZeneca PLC Company overview, Product & Services, Strategies & Financials
B. Bayer AG Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Developments
B. Future Opportunities
10. Conclusion

By Therapy:

Germany breast cancer therapeutics market can be segmented based on therapy as:

    • Chemotherapy
    • Hormone therapy
    • Targeted therapy
    • Radiation therapy
    • Others (surgery)

Among all therapies, the chemotherapy market held the largest market share in the Germany breast cancer therapeutics market.

The types of chemotherapy include adjuvant chemotherapy and neoadjuvant chemotherapy. The adjuvant chemotherapy is used to destroy cancer cells that have been spread and not seen by the imaging tests. This method helps in reducing the cancer cells that form a new tumor in the other place of the body. Adjuvant chemotherapy reduces the risk of breast cancer coming back. Neoadjuvant chemotherapy can be used to reduce the size of the tumor, so it can be removed with less widespread surgery.

By Cancer Type:

Based on the cancer type, the market is segmented into the hormone receptor and HER2+. The hormone receptor segment is likely to dominate the market during the forecast period because of the rising volume of breast cancer patients belonging to this type of cancer.

By Distribution Channel:

In lines with the global scenario, the German breast cancer therapeutics market can also be segmented based on its distribution channel capabilities as:

    • Hospital pharmacies
    • Ambulatory Surgical Centres
    • Retail pharmacies
    • Online pharmacies

The hospital pharmacies segment is projected to account for a higher share because of the dependency of patients on these pharmacies for the administration of therapies, such as chemotherapy.

By Drug Type:

Based on the drug type, the market is segmented into HER2 Inhibitors, Mitotic Inhibitors, Anti-metabolites, Aromatase Inhibitors, Hormonal Receptors.

Major Players

The companies which are contributing to the growth of the German breast cancer therapeutics market include AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, Mylan NV, Novartis International AG, F. Hoffmann-La Roche AG, Sanofi S.A., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launches, mergers, and acquisitions, collaborations with the government, and technological advancements to stay competitive in the market.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements